2517. Activity of Sulbactam-durlobactam, Antibacterial Combinations, and Comparators Against a Challenge Set of 66 Acinetobacter baumannii-calcoaceticus Species Complex Isolates

BACKGROUND: Sulbactam-durlobactam (SUL-DUR) is in clinical development for the treatment of Acinetobacter baumannii calcoaceticus species complex (ACB) isolates, including multidrug-resistant (MDR) and carbapenem-resistant strains. SUL-DUR is a combination of sulbactam, a β-lactam antibacterial with...

Descripción completa

Detalles Bibliográficos
Autores principales: Huband, Michael D, Mendes, Rodrigo E, Morgan, Gina M, Huynh, Holly, Castanheira, Mariana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678475/
http://dx.doi.org/10.1093/ofid/ofad500.2135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678475/
http://dx.doi.org/10.1093/ofid/ofad500.2135

Ejemplares similares